Pharmaceutical Technology
July 02, 2008
News
32
7
Drugmakers seeking to block the activity of a protein may have a new strategy at their disposal.
July 02, 2008
News
32
7
Staff reductions are not surprising with the state of the economy and falling pharmaceutical sales.
July 02, 2008
Online Exclusive
32
7
This review article explains how self-emulsifying drug delivery systems can increase the solubility and bioavailability of poorly soluble drug.
July 02, 2008
Online Exclusive
32
7
A new book explains process analytical technology, drug stability, and quality.
July 02, 2008
Special Section: Polymers
32
7
The authors developed a method to accurately measure the average molecular weight of large poly(ethylene glycols) (PEGs) using ion-mobility time-of-flight mass spectrometry coupled with gas-phase ion–molecule reactions.
July 02, 2008
Special Section: Polymers
32
7
A roundtable with John Doney, Jiao Yang, Hans Baer, and Elena Draganoiu.
July 02, 2008
Viewpoint
32
7
The year 2011 may seem far off, but there is much to do to prepare for electronic pedigrees.
July 02, 2008
Peer-Reviewed Research
32
7
The authors describe the factors affecting reconstitution time of dry powder for injection and classifies them as intrinsic and extrinsic parameters.
July 02, 2008
News
32
7
A growing preference for public-private partnerships is spurring innovation and technology among Dutch pharmaceutical companies.
July 02, 2008
Special Report
32
7
Natale S. Ricciardi, president of Pfizer Global Manufacturing and senior vice-president of Pfizer, discusses the company's new manufacturing focus that features plant network optimization, increased outsourcing, and greater adoption of agile or lean manufacturing.
July 02, 2008
Inside IPEC
32
7
Clear labels for substances that can be used as excipients, APIs, or both are critical to end-product use.
July 02, 2008
Agent-In-Place
32
7
They may have seemed harmless at first, but these ideas took a big bite.
July 02, 2008
PharmTech Talk
32
7
Forums, blogs, and more can spark innovation.
July 02, 2008
Special Section: Polymers
32
7
Polyethylene glycol (PEG) conjugation is a highly effective technical and commercial strategy to develop macromolecules. The authors explain the benefits and process of PEGylation and how it may be applied to small molecules.
July 02, 2008
From The Editor
32
7
With no economic relief in sight, industry, like all of us, is grappling with high-and new-costs.
July 02, 2008
Washington Report
32
7
New scientific discoveries promise to expand treatments for rare and neglected diseases.
July 02, 2008
Outsourcing Outlook
32
7
Providing the right information upfront may ease new requirements to assess solvent levels.
July 02, 2008
Peer-Reviewed Research
32
7
Patient safety must be the primary concern of any validation effort. The author explains how a risk-based approach to validation and compliance follows naturally from this premise.
July 02, 2008
Special Report
32
7
Recent reports discuss the future of pharma's emerging markets.
July 02, 2008
In the Spotlight
32
7
Editors' Picks of Pharmaceutical Science & Technology Innovations
July 02, 2008
Ingredients Insider
32
7
The year 2007 was slow for approvals for new molecular entities and overall pharmaceutical industry growth. Big Pharma seeks relief in a growing biologics portfolio.
July 02, 2008
Special Report
32
7
The pharmaceutical majors invest in biologics production capacity as they advance restructuring programs and build their pipelines